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ABSTRACT 
BACKGROUND 
Although the cytolytic, neurotoxic and 
haemolytic actions of snake venoms are well 
known, the ability of snake venom to induce 
asthma (as a distinct entity from just 
difficulty in breathing) is not previously 
reported in the literature. 
METHODS 
The case records of the patient in the index 
case and a review of existing literature using 
online search via google, medline and 
pubmed with the following key words Snake 
bite; envenomation and acute asthma were 
utilized. 
RESULT 
We report the case of a 42 year Nigerian 
fisherman, not a previously known 
asthmatic, who was bitten by a snake and 
developed acute asthma in 30 minutes. 
CONCLUSION 
Acute Asthma after snake bite in the absence 
of signs of envenomation is rare. A high 
index of suspicion is needed in identifying 
this probable condition in patients exposed 
to snake bite. There is need for further 
investigation into the pathogenesis for this 
presentation. 
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INTRODUCTION 
Snake bite is common occurrence in Nigeria 
especially in the rural areas [1], [2]. Many 
species of snakes abound in Nigeria just like in 
many other parts of the world [2], especially in 
tropical and subtropical areas where snake 
bites are a serious problem. 
It has been estimated that five million 
snakebite cases occur every year, resulting in 
about 100,000 deaths annually worldwide [3]. 
The recent categorization of snake 
envenoming as a neglected tropical disease 
(NTD) is an important advance that hopefully 
will result in the wider recognition and 
allocation of resources to this condition. 
Particularly since death from snake 
envenoming is preventable and snake anti-
venom is a very effective treatment when 
correctly administered [ 4]. 
The venomons snakes in Africa are known to 
belong to four main families the colubridae, 
elapidae, viparidae and hydrophidae, but in 
Nigeria, the most common poisonous snakes 
are the elapidae and viperidae [5]. 
Snake venoms are used primarily for attack 
and contain components designed to 
immobilize prey and facilitate their digestion. 
Over 95% of the dry weight of most venom is 
polypeptides which include enzymes, toxins, 
and small peptides, each class being capable of 
modulating the physiological response of 
envenomed animals. More than 20 enzymes 
have been detected in snake venom and 12 are 
found in majority of venoms [6]. 
Hyaluronidase is present in all snake venoms 
facilitating the distribution of other venom 
components throughout the tissue of the prey 
[6]. 
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Elapids account for the vast majority of deaths 
worldwide, particularly as a result of toxins 
that act at the neuromuscular junction. 
Systematic manifestations occur after about 
30 minutes to 1 hour and include ptosis, 
external ophthalmoplegia, dysphagia, 
salivation followed by general paresis and 
respiratory failure. These presynaptically 
acting toxins exhibit phospholipase A;. activity 
[7]. 
Cardiotoxins which cause augmentation of 
myocardial contractions at low concentration 
have been identified from cobra venoms [8]. 
Crotamine rattle snake venoms have a specific 
and unique effect on the sodium channel of 
excitable membrane [8]. Phospholipase A;. 
neurotoxins (e.g. beta bungarotoxin) have 
been shown to block potassium channels while 
a component from the venom of the rattle 
snake (crotalusatrox) affects calcium channels 
[9]. 
Haemorrhagic symptoms are a frequent 
accompaniment of bites by vipers and of some 
venomous colubrids [10]. Venom 
procoagulants activate prothrombin, and 
factor V and X. Some venom components have 
direct thrombin-like effect. Thrombocytopenia 
may occur and platelet function may be 
affected. Spontaneous systematic bleeding is 
caused by haemorrhagins which damage the 
vascular endothelium. Massive intravascular 
haemolysis leading to renal failure has also 
been reported [11]. 
The review of the literature on the clinical 
presentation and mechanism of envenomation 
with snake bite indicates a rarity of 
anaphylaxis features and even more the 
features of acute asthma attack. It is on this 
background that this case report is presented 
to draw attention to this rare manifestation 
after snake bite. 
CASE REPORT 
M.A is a 42year old male Nigerian fisherman, 
previously fit with no past medical history, 
who presented at the Accident and Emergency 
Department of our hospital with 
breathlessness, wheezing, diaphoresis, 
agitation and inability to complete sentences 
30minutes after he was bitten by a snake close 
to the bank of the river he had done fishing. 
The bite was on the left ankle. Apart from use 
of tourniquet below the knee no other form of 
treatment was given. 
His temperature was 37.4°C, the pulse rate 
was 118 per minute and his respiratory rate 
was 28 breaths per minute. The blood pressure 
was 140/80mm/Hg. Examination of the site of 
bite showed two fang marks with blood on the 
skin. The site of bite showed significant local 
swelling. He was alert with normal mental 
status. The rest of the central nervous system 
was normal. Apart from tachycardia, the 
cardiovascular system was normal. The 
breath sounds were decreased bilaterally with 
widespread wheezes. Examination of the 
abdomen was negative. His peak expiratory 
flow rate (PEFR) using a Wright peak flow 
meter gave his best reading as 130Umin 
which was less than 40% of predicted value 
[12]. A chest radiograph ruled out infiltrates, 
atelectasis and pneumothorax. He was 
hypoxic and hypocapnoeic on room air at Pa02 
12Kpa (90mmHg) and PaC02 45Kpa 
(34mmHg) respectively. His PCV was 38% and 
white cell count was 4.3 x 109/L, erythrocyte 
sedimentation rate was 48mmlhr. his serum 
sodium was 141mmol/L, potassium 
3.6mmol!L, chloride 111mmol!L, urea 
3.5mmol!L, creatinine 94p.mol/L. His partial 
thromboplastin time was 42.4 seconds and 
prothrombin time was 12.3 seconds all within 
normal limits. The ECG showed sinus 
tachycardia with no ventricular strain nor 
right axis deviation. A diagnosis of Systemic 
inflammatory response syndrome (SIRS) 
complicating snake bite was made. 
In view of the severe bronchoconstriction, 
salbultamol was given by oxygen-driven 
nebulization with aminophylline in normal 
saline infusion as it was confirmed he was not 
previously on any methylxanthine. 
Intravenous hydrocortisone was also given. 
He continued to deteriorate with the 
development of a 'silent chest'. He had killed 
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the make and came with it fu the emergency 
room but it was ditlicult for ua to identity the 
apeciaofsn.ake.(seefigura 1). 
With the marked local swelliDg andpainit was 
clear there had been envenomation. 'Thtanus 
tox:oidwasgivensincetherewaanoevideneeof 
coagulopatby. Polyvalent antivenom (5 vials of 
10mls} was given in 1 litre of normal saline 
infusion over 2haura. About an hour later he 
was observed fu be leas breathless but still 
wheezing with peak expirafury flow rate beat 
of three readings of 1981/min. This was still 
le&B than 40% a£' predicted value. His Sa02 had 
increased from 82% to 88%. Four hours later 
the antivenom was repeated after which he 
started to make significant recovery. By the 
third day of admi•~tion the beet of three 
measurement of his PEFR was 520I/min. He 
was discharged on thefift.hd~. 
DISCUSSION 
This case was found worth reporting as to the 
best of our knowledge, no such report is in the 
literature. The closest fu this report :is that by 
Prescott and Potter who reported bronchial 
aathma in anaks handiBrB from aerosolized 
snake venom as apinat snake envenomation 
[lSJ. 
Our patient did not show any signa of 
coagulopathy nor platelet dysfunction. 
Neither did he exhibit any signs to suggest 
neurotoxicity. He, however, had very 
significant local swelling with acute 
bronchoconstriction.. Even though he did well 
and was discharged over nine months ago, this 
patient in INbsequent follow-up clinic visits, 
has continued fu have recurrent episodes of 
wheezing, breathlessness and cheet tightness. 
We are at a loss as fu which of the venom's 
peptide which wru.ally include enzymes, fuxina 
and small peptides could be responsible for 
this presentatian. The identification of such 
substance, however, awaits further study. 
Ffaurel: UDfdentlfiecl make specie. 
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